Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs

Abstract Overcoming multidrug resistance has always been a major challenge in cancer treatment. Recent evidence suggested epithelial-mesenchymal transition plays a role in MDR, but the mechanism behind this link remains unclear. We found that the expression of multiple ABC transporters was elevated...

Full description

Bibliographic Details
Main Authors: Maegan Miang Kee Lim, Jonathan Wei Kiat Wee, Jen Chi Soong, Damien Chua, Wei Ren Tan, Marco Lizwan, Yinliang Li, Ziqiang Teo, Wilson Wen Bin Goh, Pengcheng Zhu, Nguan Soon Tan
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Molecular Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12943-018-0904-z
_version_ 1819027940013244416
author Maegan Miang Kee Lim
Jonathan Wei Kiat Wee
Jen Chi Soong
Damien Chua
Wei Ren Tan
Marco Lizwan
Yinliang Li
Ziqiang Teo
Wilson Wen Bin Goh
Pengcheng Zhu
Nguan Soon Tan
author_facet Maegan Miang Kee Lim
Jonathan Wei Kiat Wee
Jen Chi Soong
Damien Chua
Wei Ren Tan
Marco Lizwan
Yinliang Li
Ziqiang Teo
Wilson Wen Bin Goh
Pengcheng Zhu
Nguan Soon Tan
author_sort Maegan Miang Kee Lim
collection DOAJ
description Abstract Overcoming multidrug resistance has always been a major challenge in cancer treatment. Recent evidence suggested epithelial-mesenchymal transition plays a role in MDR, but the mechanism behind this link remains unclear. We found that the expression of multiple ABC transporters was elevated in concordance with an increased drug efflux in cancer cells during EMT. The metastasis-related angiopoietin-like 4 (ANGPTL4) elevates cellular ATP to transcriptionally upregulate ABC transporters expression via the Myc and NF-κB signaling pathways. ANGPTL4 deficiency reduced IC50 of anti-tumor drugs and enhanced apoptosis of cancer cells. In vivo suppression of ANGPTL4 led to higher accumulation of cisplatin-DNA adducts in primary and metastasized tumors, and a reduced metastatic tumor load. ANGPTL4 empowered cancer cells metabolic flexibility during EMT, securing ample cellular energy that fuels multiple ABC transporters to confer EMT-mediated chemoresistance. It suggests that metabolic strategies aimed at suppressing ABC transporters along with energy deprivation of EMT cancer cells may overcome drug resistance.
first_indexed 2024-12-21T05:50:27Z
format Article
id doaj.art-31574e4da91348bdb307ddd59eba8376
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-12-21T05:50:27Z
publishDate 2018-10-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-31574e4da91348bdb307ddd59eba83762022-12-21T19:13:59ZengBMCMolecular Cancer1476-45982018-10-011711810.1186/s12943-018-0904-zTargeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugsMaegan Miang Kee Lim0Jonathan Wei Kiat Wee1Jen Chi Soong2Damien Chua3Wei Ren Tan4Marco Lizwan5Yinliang Li6Ziqiang Teo7Wilson Wen Bin Goh8Pengcheng Zhu9Nguan Soon Tan10School of Biological Sciences, Nanyang Technological University SingaporeSchool of Biological Sciences, Nanyang Technological University SingaporeSchool of Biological Sciences, Nanyang Technological University SingaporeSchool of Biological Sciences, Nanyang Technological University SingaporeSchool of Biological Sciences, Nanyang Technological University SingaporeSchool of Biological Sciences, Nanyang Technological University SingaporeSchool of Biological Sciences, Nanyang Technological University SingaporeSchool of Biological Sciences, Nanyang Technological University SingaporeSchool of Biological Sciences, Nanyang Technological University SingaporeSchool of Biological Sciences, Nanyang Technological University SingaporeSchool of Biological Sciences, Nanyang Technological University SingaporeAbstract Overcoming multidrug resistance has always been a major challenge in cancer treatment. Recent evidence suggested epithelial-mesenchymal transition plays a role in MDR, but the mechanism behind this link remains unclear. We found that the expression of multiple ABC transporters was elevated in concordance with an increased drug efflux in cancer cells during EMT. The metastasis-related angiopoietin-like 4 (ANGPTL4) elevates cellular ATP to transcriptionally upregulate ABC transporters expression via the Myc and NF-κB signaling pathways. ANGPTL4 deficiency reduced IC50 of anti-tumor drugs and enhanced apoptosis of cancer cells. In vivo suppression of ANGPTL4 led to higher accumulation of cisplatin-DNA adducts in primary and metastasized tumors, and a reduced metastatic tumor load. ANGPTL4 empowered cancer cells metabolic flexibility during EMT, securing ample cellular energy that fuels multiple ABC transporters to confer EMT-mediated chemoresistance. It suggests that metabolic strategies aimed at suppressing ABC transporters along with energy deprivation of EMT cancer cells may overcome drug resistance.http://link.springer.com/article/10.1186/s12943-018-0904-zEpithelial-mesenchymal transitionMulti-drug resistanceAngiopoietin-like 4ATP-binding cassette transporters
spellingShingle Maegan Miang Kee Lim
Jonathan Wei Kiat Wee
Jen Chi Soong
Damien Chua
Wei Ren Tan
Marco Lizwan
Yinliang Li
Ziqiang Teo
Wilson Wen Bin Goh
Pengcheng Zhu
Nguan Soon Tan
Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs
Molecular Cancer
Epithelial-mesenchymal transition
Multi-drug resistance
Angiopoietin-like 4
ATP-binding cassette transporters
title Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs
title_full Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs
title_fullStr Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs
title_full_unstemmed Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs
title_short Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs
title_sort targeting metabolic flexibility via angiopoietin like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs
topic Epithelial-mesenchymal transition
Multi-drug resistance
Angiopoietin-like 4
ATP-binding cassette transporters
url http://link.springer.com/article/10.1186/s12943-018-0904-z
work_keys_str_mv AT maeganmiangkeelim targetingmetabolicflexibilityviaangiopoietinlike4proteinsensitizesmetastaticcancercellstochemotherapydrugs
AT jonathanweikiatwee targetingmetabolicflexibilityviaangiopoietinlike4proteinsensitizesmetastaticcancercellstochemotherapydrugs
AT jenchisoong targetingmetabolicflexibilityviaangiopoietinlike4proteinsensitizesmetastaticcancercellstochemotherapydrugs
AT damienchua targetingmetabolicflexibilityviaangiopoietinlike4proteinsensitizesmetastaticcancercellstochemotherapydrugs
AT weirentan targetingmetabolicflexibilityviaangiopoietinlike4proteinsensitizesmetastaticcancercellstochemotherapydrugs
AT marcolizwan targetingmetabolicflexibilityviaangiopoietinlike4proteinsensitizesmetastaticcancercellstochemotherapydrugs
AT yinliangli targetingmetabolicflexibilityviaangiopoietinlike4proteinsensitizesmetastaticcancercellstochemotherapydrugs
AT ziqiangteo targetingmetabolicflexibilityviaangiopoietinlike4proteinsensitizesmetastaticcancercellstochemotherapydrugs
AT wilsonwenbingoh targetingmetabolicflexibilityviaangiopoietinlike4proteinsensitizesmetastaticcancercellstochemotherapydrugs
AT pengchengzhu targetingmetabolicflexibilityviaangiopoietinlike4proteinsensitizesmetastaticcancercellstochemotherapydrugs
AT nguansoontan targetingmetabolicflexibilityviaangiopoietinlike4proteinsensitizesmetastaticcancercellstochemotherapydrugs